Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Parsons

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Postgraduate Medical Journal|February 12, 2011
The Treatment of Acute Leukaemia in Adults with CyclophosphamideM J Meynell, C G Parsons
British Journal of Pharmacology|October 1, 1989
Spinal antinociceptive actions of mu- and kappa-opioids: the importance of stimulus intensity in determining 'selectivity' between reflexes to different modalities of noxious stimulusC G Parsons, P M Headley
Amino Acids|October 12, 2000
NMDA channel blockers: memantine and amino-aklylcyclohexanes--in vivo characterizationW Danysz, C G Parsons, G Quack
Neuropharmacology|August 28, 1999
Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical dataC G Parsons, W Danysz, G Quack
Neuropharmacology|March 23, 2000
Differential effects of NMDA-receptor antagonists on long-term potentiation and hypoxic/hypoglycaemic excitotoxicity in hippocampal slicesT Frankiewicz, A Pilc, C G Parsons
Neuropharmacology|May 1, 1994
Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methyl-endioxyl-5H-2,3-benzodiaze pine (GYKI 52466)C G Parsons, R Gruner, J Rozental
Drug News & Perspectives|December 24, 2004
Glutamate in CNS disorders as a target for drug development: an updateC G Parsons, W Danysz, G Quack
Handbook of Experimental Pharmacology|April 6, 2006
Excitatory amino acid neurotransmissionC G Parsons, W Danysz, W Zieglgänsberger
Current Neuropharmacology|March 24, 2009
Pharmacodynamics of memantine: an updateG Rammes, W Danysz, C G Parsons
Neuropharmacology|August 26, 1998
Budipine is a low affinity, N-methyl-D-aspartate receptor antagonist: patch clamp studies in cultured striatal, hippocampal, cortical and superior colliculus neuronesC G Parsons, S Hartmann, P Spielmanns
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Postgraduate Medical Journal|February 12, 2011
The Treatment of Acute Leukaemia in Adults with CyclophosphamideM J Meynell, C G Parsons
British Journal of Pharmacology|October 1, 1989
Spinal antinociceptive actions of mu- and kappa-opioids: the importance of stimulus intensity in determining 'selectivity' between reflexes to different modalities of noxious stimulusC G Parsons, P M Headley
Amino Acids|October 12, 2000
NMDA channel blockers: memantine and amino-aklylcyclohexanes--in vivo characterizationW Danysz, C G Parsons, G Quack
Neuropharmacology|August 28, 1999
Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical dataC G Parsons, W Danysz, G Quack
Neuropharmacology|March 23, 2000
Differential effects of NMDA-receptor antagonists on long-term potentiation and hypoxic/hypoglycaemic excitotoxicity in hippocampal slicesT Frankiewicz, A Pilc, C G Parsons
Neuropharmacology|May 1, 1994
Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methyl-endioxyl-5H-2,3-benzodiaze pine (GYKI 52466)C G Parsons, R Gruner, J Rozental
Drug News & Perspectives|December 24, 2004
Glutamate in CNS disorders as a target for drug development: an updateC G Parsons, W Danysz, G Quack
Handbook of Experimental Pharmacology|April 6, 2006
Excitatory amino acid neurotransmissionC G Parsons, W Danysz, W Zieglgänsberger
Current Neuropharmacology|March 24, 2009
Pharmacodynamics of memantine: an updateG Rammes, W Danysz, C G Parsons
Neuropharmacology|August 26, 1998
Budipine is a low affinity, N-methyl-D-aspartate receptor antagonist: patch clamp studies in cultured striatal, hippocampal, cortical and superior colliculus neuronesC G Parsons, S Hartmann, P Spielmanns
Pageof 8